商品簡介
?Classically, photo atlases of retinal dystrophies have been divided into sections that describe and depict a particular retinal finding or disease, after which a differential diagnosis of potential diseases or mutated genes is provided. However, given the pace of improvement in molecular diagnostics, availability of free mutation screening from the NIH, and the exponential increase in our understanding of the phenotypes caused by each mutated gene, the paradigm has changed to where physicians now think of variable expression of each individual gene. Therefore, Retinal Dystrophy Gene Atlas catalogs the different phenotypes that are possible with each mutated gene. Each section describes a gene and all its possible clinical phenotypes and patient characteristics, along with retinal photos depicting each possible phenotype. Written by prominent retinal dystrophy specialists from the largest dystrophy centers worldwide, Retinal Dystrophy Gene Atlas contains more than 100 chapters, each of which describes the clinical and photographic manifestations of a specific gene. The chapters are organized into one of three sections based on the inheritance pattern (Autosomal Dominant, Autosomal Recessive, or X-linked) and will include stunning clinical color photographs of the retina, autofluorescence imaging, and electrophysiologic findings and cross-sectional imaging. Retinal Dystrophy Gene Atlas will serve as a resource to aid genetic diagnosis in patients with retinal dystrophies by more than 2,400 retina specialists and pediatric ophthalmologists in the United States, as well as hundreds of fellows and residents that enter the workforce each year.
作者簡介
Thiran Jayasundera, M.D., FRCSC, FRANZCO is an Assistant Professor of Ophthalmology and Visual Sciences at the University of Michigan Kellogg Eye Center and his interests are in diseases of the retina and vitreous including retinal detachment, diabetic retinopathy, retinal vascular diseases, macular diseases, age-related macular degeneration, surgical management of complex retinal detachments, anti-angiogenic therapy and photodynamic therapy. Mark Pennesi, MD, PhD., is an Assistant Professor in Genetics at the Casey Eye Institute and is a member of the Oregon Retinal Degeneration Center. He also serves as the Head of the Ophthalmic Imaging Department at Casey. The Foundation Fighting Blindness has recognized Dr. Pennesi with a Career Development Award to support his ambition to conduct transitional research that will bring treatments for diseases such as retinitis pigmentosa from the laboratory to the clinic. His research focuses on developing novel treatments for inherited retinal diseases. He is currently exploring the potential of a new class of drugs to up regulate protective growth factors in the retina. Michel Michaelides is a Consultant Ophthalmologist at Moorfields Eye Hospital in the departments of Medical Retina, Inherited Eye Disease and Paediatric Ophthalmology. He has undertaken a medical retina and genetics clinical fellowship at Moorfields Eye Hospital, and a combined genetics and paediatric ophthalmology clinical and research fellowship at Casey Eye Institute, Portland, OR. Sarwar Zahid, MD is a resident physician at Henry Ford Health System.
